Wednesday, May 06, 2020 7:31:37 PM
Recent LH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/25/2024 01:26:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/24/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 10:58:10 AM
- Labcorp Announces 2024 Third Quarter Results • PR Newswire (US) • 10/24/2024 10:50:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/18/2024 06:51:42 PM
- NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. • Business Wire • 10/16/2024 12:00:00 PM
- Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test • PR Newswire (US) • 10/10/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 10:58:48 AM
- Labcorp Declares Quarterly Dividend • PR Newswire (US) • 10/10/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:21:05 PM
- Labcorp to Announce Third Quarter Financial Results on October 24, 2024 • PR Newswire (US) • 09/24/2024 08:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:18:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 08:05:59 PM
- Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience • PR Newswire (US) • 09/18/2024 11:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/18/2024 10:12:36 AM
- LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034 • PR Newswire (US) • 09/16/2024 10:35:00 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 09/16/2024 09:30:56 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/16/2024 12:21:09 PM
- Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health • PR Newswire (US) • 09/16/2024 11:30:00 AM
- Labcorp to Speak at the Baird 2024 Global Healthcare Conference • PR Newswire (US) • 09/03/2024 08:09:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 02:16:00 PM
- Labcorp Finalizes Acquisition of Select Assets of Invitae • PR Newswire (US) • 08/05/2024 11:00:00 AM
- Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx • PR Newswire (US) • 08/02/2024 12:30:00 PM
- Labcorp Announces 2024 Second Quarter Results • PR Newswire (US) • 08/01/2024 10:57:00 AM
- Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities • PR Newswire (US) • 07/30/2024 11:00:00 AM
Vocodia Enters Medical Alert Industry with Innovative Emergency Response Pendant • VHAI • Oct 25, 2024 8:00 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 • HYDI • Oct 24, 2024 11:18 AM
VAYK Asserts Goal of Q4 Operationally Profitable and Projects Major 2025 Launch • VAYK • Oct 24, 2024 10:40 AM
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push • CBDL • Oct 24, 2024 7:07 AM
ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition • AVXL • Oct 23, 2024 8:03 AM
Forte Minerals to Acquire the Miscanthus Epithermal Gold and Porphyry Copper Prospects in Central Perú with Environmental Drilling Permit (DIA) • CUAU • Oct 23, 2024 7:38 AM